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Spinal epidural hematoma is a rare but serious neurological complication of neuraxial anesthesia.  Enoxaparin 
sodium is a low molecular weight heparin (LMWH) for use in preventing deep venous thrombosis in patients 
undergoing total hip arthroplasty and total knee arthroplasty.  Hemorrhage is an uncommon but documented 
adverse reaction when using LMWH.  We report a case of epidural hematoma after lumbar epidural anesthesia in a 
patient who administered enoxaparin in perioperative period.  (Korean J Anesthesiol 2010; 59: 119-122)
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    Anticoagulants, antiplatelet drugs, glycoprotein IIb/IIIa 
antagonists, and thrombolytics are used for the prevention 
and treatment of stroke, myocardial infarction, deep vein 
thrombosis, and pulmonary embolism in many patients 
undergoing surgery [1]. Among them, low molecular weight 
heparin (LMWH) has been excellent safety and efficacy without 
need of laboratory monitoring. However, reports of spinal 
hematoma occurring spontaneously and in association with 
regional anesthesia [2-4] have generated concern about the 
safety of spinal or epidural anesthesia in patients receiving 
LMWH. We report a case of an epidural hematoma in a patient 
who was administered enoxaparin (LMWH) prophylactically 
against the development of deep vein thrombosis periope-
ratively and received lumbar continuous epidural anesthesia.
Case Report
    An American Society of Anesthesiologists physical state III, 
82-year-old man who had previously undergone both total hip 
arthroplasty was admitted for an elective left revisional total 
hip arthroplasty. He had bronchial asthma, moderate chronic 
airway limitation, and poor exercise tolerance. Pulmonary 
function test showed a forced expiratory volume in 1 second 
of 0.73 L (52% predicted) and forced vital capacity of 2.09 L 
(94% predicted). He was treated with xanthines, mucolytics, 
and inhalater for bronchial asthma. Spinal radiograph showed 
moderate osteoporotic compression fracture of the lumbar 
and lower thoracic spine. His routine preoperative blood 
investigations revealed normal electrolytes, hematocrit 120 www.ekja.org
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(Hct) of 35.6%, platelet count of 440,000/mm
3, prothrombin 
time of 90.5% (normal range, 72-161%), activated partial 
thromboplastin time of 35.2 seconds (normal range, 21-38 
seconds), with an international normalized ratio (INR) of 1.05 
(therapeutic level, 0.7-1.24).
    Perioperative thromboprophylaxis with enoxaparin (Aventis 
Pharma, Seoul, Korea) 40 mg subcutaneously once daily was 
planned by surgical team and initiated enoxaparin 20 mg the 
evening before surgery. The next morning at 8 a.m, epidural 
anesthesia was performed by an experienced anesthesiologist. 
A 17-gauge Tuohy needle was introduced at the level of the L4-5 
interspace using a midline approach and a 19-gauge epidural 
catheter (ARROW
Ⓡ, Arrow International Inc., Reading, PA, USA) 
advanced 3 cm into the epidural space. The epidural space was 
identified using the loss of resistance technique and an air-filled 
syringe. The procedures were atraumatic with no paresthesia 
or blood in the catheter. The epidural test dose (3 ml of 1.5% 
lidocaine with epinephrine 1 : 200,000) and an additional 12 
ml of 1.5% lidocaine was administered via epidural catheter. 
General anesthesia was conducted using a laryngeal mask 
airway (LMA) and maintained under sevoflurane-nitrous 
oxide-oxygen. Surgery was completed uneventfully and the 
catheter was removed intact before transporting him to the 
postanesthesia care unit. No blood was observed on the catheter 
or at the insertion site. Since we were anxious about the aseptic 
maintenance and the safety of using enoxaparin in a patient 
with indwelling catheter for postoperative analgesia, the 
catheter was removed in the operating room.
    The patient recovered uneventfully from the epidural 
anesthetic. That evening, enoxaparin 40 mg administered 
subcutaneously. The second dose time of the enoxaparin (LMWH) 
was 2 hours after the removal of the epidural catheter. On the 
evening of the second postoperative day, 4 hours after the 
fourth enoxaparin administration, the patient complained 
reduced sensation of the right, nonoperated leg as well as 
motor weakness of the left leg. No back pain was reported. 
Emergency magnetic resonance imaging revealed T8-L5 
epidural hematoma with cord compression (Fig. 1). Emergency 
decompressive laminectomy to evacuate the hematoma was 
performed. There was a delay of 5 hours after the neurosurgical 
decision because of family’s refusal. No vascular malformation 
was seen. Before the second surgical procedure, coagulation 
profile was showed as hemoglobin 6.4 g/dl, Hct 18.9%, 
prothrombin time 49.8%, activated partial thromboplastin time 
63.1 seconds, international normalized ratio 1.49, fibrinogen 71 
mg/dl (normal range, 80-415), antithrombin III 54% (normal 
range, 60-90%), D-dimer 461 ng/ml (normal range, 0-322), 
and a platelet count of 129,000/mm
3. Postoperatively there was 
no improvement in neurologic function. Twelve packed red 
blood cells and 5 fresh frozen plasmas were used from the initial 
operation to the second operation. The patient subsequently 
expired from myocardial infarction attack 2 days later.
Discussion
    Patients undergoing total hip arthroplasty are at increased 
risk for deep venous thrombosis and pulmonary embolism. 
Without prophylaxis, the prevalence of deep venous thrombosis 
is 51% [5] and that of fatal pulmonary embolism is 2% [6]. 
The fact that regional anesthesia reduces the risk of venous 
thromboembolism is well known. LMWH is an effective antith-
rombotic agent for total hip arthroplasty patients. Therefore, 
neuraxial anesthesia and postoperative analgesia with early 
pharmacologic prophylaxis would appear to be the most 
efficacious approach toward preventing thromboembolic 
complications.
    LMWH has become a popular drug in many institutions 
because it provides safe and effective prophylaxis of deep 
venous thrombosis. However, its use is being associate with an 
increasing incidence of spinal hematoma following neuraxial 
blockade. Estimates of spinal hematoma in patients receiving 
LMWH were higher at 33 : 100,000 in those undergoing epidural 
technique and 1 : 100,000 in those receiving spinal anesthesia [7] 
compared with incidence of 1 : 150,000 after an epidural block 
and 1 : 220,000 after a spinal block [8]. Anatomical, technical, 
and pharmacological factors, including vertebral spine 
abnormalities, traumatic spinal tap, multiple attempts at needle 
placement, and use of antiplatelet and anticoagulant therapy 
may be implicated in formation of spinal epidural hematoma 
[4]. Several factors suspected of predisposing patients to 
Fig. 1. Spine sagital magnetic resonance image showing the epidural 
hematoma (arrows) in the posterior epidural space along T8-L5 with 
resultant compression of the spinal cord and thecal sac.121 www.ekja.org
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epidural hematoma include a dose of enoxaparin that exceeds 
the recommended dose, administration of enoxaparin to 
surgical patients before the establishment of hemostasis, 
use of epidural catheters, concomitant administration of 
medications affecting hemostasis, presence of vertebral column 
abnormalities, advanced age, and female gender [3,4,9]. The 
study performed by Vandermeulen et al. [9] revealed that major 
of spinal hematoma (87%) resulted from impaired hemostais 
or difficulty in needle placement. In the country, there is a 
epidural hematoma case after epidural catheterization without 
coagulopathy [10]. The etiology of spinal epidural hematoma 
is unknown, but Miyazaki et al. [11] mentioned that a small 
injury or high intracavity pressure could lead to rupture and 
hematoma since posterior vertebral and epidural veins are very 
fragile. 
    LMWH have a dose-dependent bleeding potential [12,13]. 
It is interesting to note that in North America the approved 
dose of enoxaparin is 30 mg twice daily while in Europe a 40 
mg single daily dose is used [4,5,9,14]. The higher dose used in 
North America may have contributed to the apparent increase 
in anticoagulant related epidural hematoma [9,12-14]. This case 
used European practice guidelines for the use of LMWH. The 
use of low dose LMWH does not usually require monitoring 
of the anticoagulant effect because of the predictability of its 
effect [12,13]. However, the use of high dose LMWH in elderly 
patients with multisystem disease probably requires laboratory 
monitoring [12]. It would be likely that in the elderly, there is an 
impairment of the renal function with decreased drug clearance, 
although there are many factors that alter drug levels and 
sensitivity in old people. The activated partial thromboplastin 
time and anti-Xa level are measures of LMWH anticoagulant 
effect. Peak anti-Xa levels of 0.1-0.2 U/ml provide safe and 
effective venous thromboembolism prophylaxis after hip or 
knee replacement surgery [14]. The timing of the dose of LMWH 
has a noctable effect on the occurrence of major bleeding. 
LMWH rapidly achieves peak levels within 3 to 5 hours after 
subcutaneous administration and reached 50% of their peak 
values 12 hours after injection [4,9]. The timing of the initial 
dose in orthopedic patients varies, with LMWH administered 12 
hours preoperatively in Europe and 12-24 hours postoperatively 
in North America [4,14]. European practice guidelines may in 
fact be a good approach for intraoperative DVT. But, because 
hemostasis is not established in most patients until twelve to 
twenty four hours postoperatively, delaying the administration 
of the first dose of enoxaparin until this point ensures that the 
wound has stabilized. The acute spinal epidural hematoma in 
this elderly patient may be caused by spontaneous bleeding 
in the presence of relatively high dose enoxaparin through 
administration of enoxaparin before the establishment of 
hemostasis.
    Catheter removal is also another important consideration 
in epidural anesthesia. Vandermeulen et al. [9] reported that 
spinal anesthesia was less traumatic than epidural anesthesia 
and catheter removal was significant in the development of 
spinal bleeding. Removal of catheter appeared to more critical 
than the insertion of epidural catheter in the genesis of a spinal 
hematoma, because bleeding occurred at removal moment in 
almost half of the cases [9]. Several authors [9,14] suggested 
that catheter removal and the patient’s coagulation status at the 
time of removal are critical factors in the development of spinal 
bleeding. Miyazaki et al. [11] reported that in 50%, the initial 
symptoms of spinal epidural hematoma were recognized within 
24 hours of the removal of an epidural catheter and the injury 
to vessels caused by removal of an epidural catheter can lead 
to formation of spinal epidural hematoma. The major of cases 
occurred with catheter removal, suggesting that the catheter 
provided a mechanical tamponade that becomes dislodged 
with catheter removal. We deduce epidural hematoma from 
impaired hemostasis due to continuative enoxaparin therapy 
in the postoperative period. The American Society of Regional 
Anesthesia (ASRA) recommended that one must wait at least 
10 to 12 hours after the last dose of LMWH to withdraw the 
catheter and then wait another 2 hours before giving the next 
LMWH dose [1,8,9,13]. In this case, the epidural catheter was 
removed 16 hours after the first dose of LMWH and the second 
dose of LMWH was administered 2 hours after catheter removal. 
Despite adhering to ASRA guideline concerning LMWH 
application, and despite the fact that preoperative clotting tests 
were normal, this patient developed an epidural hematoma 2 
days after removal of epidural catheter. Accordingly, even if an 
atraumatic epidural or spinal anesthesia is, special precautions 
must be observed when removing the catheter in the patient 
administering LMWH.
    It is very important to diagnose spinal hematomas early 
on so that prompt investigation and treatment are initiated. 
The first neuromuscular symptom of spinal hematoma was 
muscle weakness in 46% of patients and sensory deficit in 
14% of patients in the work performed by Vandermeulen et 
al. [9]. Although the cardinal symptom of epidural hematoma 
is severe back pain, most patients reported sensory or motor 
deficits that progressed to paralysis, with the onset of symptoms 
occurring about 2 to 3 days after enoxaparin therapy had been 
initiated [3,4]. So, monitoring for signs of cord compression 
in the perioperative period is crucial with the typical initial 
complaint being new-onset weakness or numbness, not severe 
radicular back pain, as one might suspect. This patient also had 
not severe back pain but progressive numbness and weakness. 
Clinical factors influencing the neurologic prognosis are the 
severity of the pre-operative neurologic deficits, speed of onset 
of clinical signs, location of hematoma, age, duration of spinal 122 www.ekja.org
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cord compression, and the operative interval between onset of 
clinical signs and surgical evacuation [9,11,15]. It may also be 
possible that increased vigilance and early surgical intervention 
herald better outcomes. Although we followed the lead of 
ASRA guidelines about the LMWH application, the abnormal 
neurology showed 3 days after initiation of LMWH therapy 
and 2 days after catheter removal. We consider five points to 
be of possibility in this case. First, impaired renal function with 
decreased drug clearance in the elderly may result in drug levels 
and sensitivity changes. Second, even if the procedure itself was 
atraumatic, the injury to vessels caused by removal of epidural 
catheter could form spinal epidural hematoma. Third, the 
next LMWH within relatively short time (2 hours) of catheter 
removal might aggravate the patient’s hemostasis for 12 to 24 
hours postoperative period. Fourth, the consecutive LMWH 
administration without adjustment of coagulation state might 
cause the enlargement of hematoma. Finally, the disseminated 
intravascular coagulation through massive transfusion also 
may break down the patient’s homeostasis, and result in the 
expansion of hematoma volumes. Response to subcutaneous 
LMWH therapy remains speculative, as subcutaneous blood 
flow may vary considerably interindividually in the elderly and 
may result in therapeutic anticoagulation. So, since the elderly is 
a risk factor for bleeding during treatment with LMWH, careful 
evaluation of individual hemorrhagic risk, a slight decrease of 
doses, atraumatic technique and careful laboratory monitoring 
are recommended.
    In conclusion, the potential development of a spinal hematoma 
in patients receiving neuraxial anesthesia must always be kept 
in mind whether of not an anticoagulant was used. Patients 
anticoagulated or scheduled to be anticoagulated with LMWH 
or heparinoids for prevention of thromboembolic complication 
are at risk of developing an epidural or spinal hematoma after 
neuraxial anesthesia or spinal puncture. The risk of these events 
is increased by the use of indwelling epidural catheters for 
administration of analgesia or by the concomitant use of drug 
affecting hemostasis such as non steroidal anti-inflammatory 
drugs, platelet inhibitors, or other anticoagulants or by old age. 
Since early diagnosis of an epidural hematoma after initial 
symptom and early surgery might have improved outcome, 
we should closely monitor patients for early signs of cord 
compression, such as progressive numbness or weakness, 
and bowel and bladder dysfunction after lumbar epidural 
anesthesia in a patient who administered enoxaparin in 
perioperative period.
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